Beam Therapeutics (BEAM) Profit After Tax (2019 - 2026)
Beam Therapeutics (BEAM) reported Profit After Tax of -$94.3 million for Q1 2026, up 12.93% year-over-year from -$83.5 million in Q1 2025, and down 138.61% on a QoQ basis from $244.3 million in Q4 2025.
Beam Therapeutics (BEAM) has 8 years of Profit After Tax data on file, last reported at -$94.3 million in Q1 2026.
- Quarterly Profit After Tax rose 12.93% year-over-year to -$94.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.6 million (up 138.71% YoY) and the FY2025 annual result came in at -$80.0 million, up 78.77% from the prior year.
- Profit After Tax fell to -$94.3 million in Q1 2026 per BEAM's latest filing, from $244.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at $244.3 million in Q4 2025 and bottomed at -$109.6 million in Q3 2022.
- The 5-year median for Profit After Tax is -$90.4 million (2024), against an average of -$44.5 million.
- The widest annual swing landed in 2022, when Profit After Tax sank 289.7%; it then surged 472.36% in 2023.
- Tracing BEAM's Profit After Tax over 5 years: stood at -$38.3 million in 2022, then surged by 472.36% to $142.8 million in 2023, then slumped by 163.27% to -$90.4 million in 2024, then soared by 370.38% to $244.3 million in 2025, then plunged by 138.61% to -$94.3 million in 2026.
- Per Business Quant, the three latest BEAM Profit After Tax figures stand at -$94.3 million (Q1 2026), $244.3 million (Q4 2025), and -$200000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | -94.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.32 Mn |
| Dec 31, 2025 | 244.30 Mn |
| Sep 30, 2025 | -200,000.00 |
| Jun 30, 2025 | -200,000.00 |
| Mar 31, 2025 | -108.33 Mn |
| Dec 31, 2024 | -90.35 Mn |
| Sep 30, 2024 | -96.67 Mn |
| Jun 30, 2024 | -91.05 Mn |
| Mar 31, 2024 | -98.67 Mn |
| Dec 31, 2023 | 142.80 Mn |
| Sep 30, 2023 | -96.09 Mn |
| Jun 30, 2023 | -82.78 Mn |
| Mar 31, 2023 | -96.46 Mn |
| Dec 31, 2022 | -38.35 Mn |
| Sep 30, 2022 | -109.58 Mn |
| Jun 30, 2022 | -71.95 Mn |
| Mar 31, 2022 | -69.21 Mn |
| Dec 31, 2021 | -64.71 Mn |
| Sep 30, 2021 | -28.12 Mn |
| Jun 30, 2021 | -76.25 Mn |
| Mar 31, 2021 | -201.56 Mn |
| Dec 31, 2020 | -95.46 Mn |
| Sep 30, 2020 | -34.45 Mn |
| Jun 30, 2020 | -34.22 Mn |
| Mar 31, 2020 | -30.46 Mn |
| Dec 31, 2019 | -27.85 Mn |
| Sep 30, 2019 | -19.01 Mn |
| Jun 30, 2019 | -17.86 Mn |
| Mar 31, 2019 | -13.61 Mn |